221 related articles for article (PubMed ID: 11159082)
21. Mapping sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue-dye, and intraoperative gamma-probe.
Mariani G; Villa G; Gipponi M; Bianchi P; Buffoni F; Agnese G; Vecchio C; Tomei D; Carli F; Nicolò G; Canavese G
Cancer Biother Radiopharm; 2000 Jun; 15(3):245-52. PubMed ID: 10941531
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification.
Valdés-Olmos RA; Jansen L; Hoefnagel CA; Nieweg OE; Muller SH; Rutgers EJ; Kroon BB
J Nucl Med; 2000 Sep; 41(9):1500-6. PubMed ID: 10994729
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of axillary ultrasound in the quality assessment of sentinel node biopsy in breast cancer surgery.
Paajanen H; Kilponen VM; Heikkinen J; Sammalkorpi H; Helle M
Scand J Surg; 2006; 95(3):195-8. PubMed ID: 17066617
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic mapping with intralesional tracer administration in breast carcinoma patients.
Doting MH; Jansen L; Nieweg OE; Piers DA; Tiebosch AT; Koops HS; Rutgers EJ; Kroon BB; Peterse JL; Olmos RA; de Vries J
Cancer; 2000 Jun; 88(11):2546-52. PubMed ID: 10861432
[TBL] [Abstract][Full Text] [Related]
25. [Contribution of nuclear medicine to lymphatic mapping and sentinel node identification in oncology].
Valdés Olmos RA; Jansen L; Muller SH; Hoefnagel CA; Nieweg O
Rev Esp Med Nucl; 1999; 18(2):111-21. PubMed ID: 10352326
[TBL] [Abstract][Full Text] [Related]
26. Results of preoperative lymphoscintigraphy for breast cancer are predictive of identification of axillary sentinel lymph nodes.
Marchal F; Rauch P; Morel O; Mayer JC; Olivier P; Leroux A; Verhaeghe JL; Guillemin F
World J Surg; 2006 Jan; 30(1):55-62. PubMed ID: 16369717
[TBL] [Abstract][Full Text] [Related]
27. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer.
Pijpers R; Meijer S; Hoekstra OS; Collet GJ; Comans EF; Boom RP; van Diest PJ; Teule GJ
J Nucl Med; 1997 Mar; 38(3):366-8. PubMed ID: 9074519
[TBL] [Abstract][Full Text] [Related]
28. Is blue dye indicated for sentinel lymph node biopsy in breast cancer patients with a positive lymphoscintigram?
Degnim AC; Oh K; Cimmino VM; Diehl KM; Chang AE; Newman LA; Sabel MS
Ann Surg Oncol; 2005 Sep; 12(9):712-7. PubMed ID: 16079955
[TBL] [Abstract][Full Text] [Related]
29. [Lymphoscintigraphy in sentinel lymph node biopsy of breast cancer].
Zhang J; Shen K; Nirmal L; Liu G; Wu J; Zhang Y; Du H; Pan Z; Shao Z; Shen Z
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):616-8. PubMed ID: 12667340
[TBL] [Abstract][Full Text] [Related]
30. [Less axillary dissection necessary due to sentinel node biopsy in patients with breast carcinoma].
Meijer S; Collet GJ; Pijpers HJ; van Hattum L; Hoekstra OS
Ned Tijdschr Geneeskd; 1996 Nov; 140(45):2239-43. PubMed ID: 8984370
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymphoscintigraphy in patients with breast cancer undergoing excisional biopsy.
Ohtake E; Asaga T; Inaba M
Ann Nucl Med; 2005 Dec; 19(8):671-5. PubMed ID: 16444992
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node mapping in breast cancer: a critical reappraisal of the internal mammary chain issue.
Manca G; Volterrani D; Mazzarri S; Duce V; Svirydenka A; Giuliano A; Mariani G
Q J Nucl Med Mol Imaging; 2014 Jun; 58(2):114-26. PubMed ID: 24835288
[TBL] [Abstract][Full Text] [Related]
33. Sentinel node biopsy in male breast cancer.
De Cicco C; Baio SM; Veronesi P; Trifirò G; Ciprian A; Vento A; Rososchansky J; Viale G; Paganelli G
Nucl Med Commun; 2004 Feb; 25(2):139-43. PubMed ID: 15154702
[TBL] [Abstract][Full Text] [Related]
34. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
35. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
36. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
[TBL] [Abstract][Full Text] [Related]
37. Added value of blue dye injection in sentinel node biopsy of breast cancer patients: do all patients need blue dye?
Sadeghi R; Alesheikh G; Zakavi SR; Fattahi A; Abdollahi A; Assadi M; Jangjoo A; Keshtgar M
Int J Surg; 2014; 12(4):325-8. PubMed ID: 24486686
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer.
Jansen L; Doting MH; Rutgers EJ; de Vries J; Olmos RA; Nieweg OE
Br J Surg; 2000 Jul; 87(7):920-5. PubMed ID: 10931029
[TBL] [Abstract][Full Text] [Related]
39. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients.
Wu CT; Morita ET; Treseler PA; Esserman LJ; Hwang ES; Kuerer HM; Santos CL; Leong SP
Breast J; 2003; 9(2):86-90. PubMed ID: 12603380
[TBL] [Abstract][Full Text] [Related]
40. Sentinel node identification by scintigraphic methods in cutaneous melanoma.
Dias Moreira R; Altino de Almeida S; Maliska Guimarães CM; Resende JF; Gutfilen B; Barbosa da Fonseca LM
J Exp Clin Cancer Res; 2005 Jun; 24(2):181-5. PubMed ID: 16110749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
